Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Single-Arm, Open-Label Clinical Trial of the Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma

NCT07220876 is registered in ClinicalTrials.gov with Avisi Technologies Inc. as lead sponsor.

NCT NCT07220876
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07220876 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Single-Arm, Open-Label Clinical Trial of the Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma
Lead sponsor
Avisi Technologies Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
November 7, 2025
Completion date
October 31, 2027
Enrollment
165 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

open angle glaucoma (oag)